Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ALKEM LABORATORIES PROCTER & GAMBLE HEALTH/
ALKEM LABORATORIES
 
P/E (TTM) x 34.5 37.5 91.9% View Chart
P/BV x 10.5 6.5 161.0% View Chart
Dividend Yield % 2.0 1.0 199.4%  

Financials

 PROCTER & GAMBLE HEALTH   ALKEM LABORATORIES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
ALKEM LABORATORIES
Mar-23
PROCTER & GAMBLE HEALTH/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs5,3663,625 148.0%   
Low Rs3,8832,835 137.0%   
Sales per share (Unadj.) Rs740.7970.1 76.4%  
Earnings per share (Unadj.) Rs138.284.2 164.2%  
Cash flow per share (Unadj.) Rs155.2110.2 140.8%  
Dividends per share (Unadj.) Rs95.0050.00 190.0%  
Avg Dividend yield %2.11.5 132.7%  
Book value per share (Unadj.) Rs447.6756.4 59.2%  
Shares outstanding (eoy) m16.60119.57 13.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.23.3 187.5%   
Avg P/E ratio x33.538.4 87.2%  
P/CF ratio (eoy) x29.829.3 101.6%  
Price / Book Value ratio x10.34.3 241.9%  
Dividend payout %68.759.4 115.7%   
Avg Mkt Cap Rs m76,761386,207 19.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2,06221,314 9.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,296115,993 10.6%  
Other income Rs m1842,161 8.5%   
Total revenues Rs m12,480118,153 10.6%   
Gross profit Rs m3,24715,065 21.6%  
Depreciation Rs m2813,104 9.1%   
Interest Rs m81,074 0.7%   
Profit before tax Rs m3,14213,048 24.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8472,980 28.4%   
Profit after tax Rs m2,29510,068 22.8%  
Gross profit margin %26.413.0 203.3%  
Effective tax rate %27.022.8 118.1%   
Net profit margin %18.78.7 215.0%  
BALANCE SHEET DATA
Current assets Rs m11,71386,064 13.6%   
Current liabilities Rs m6,79137,071 18.3%   
Net working cap to sales %40.042.2 94.8%  
Current ratio x1.72.3 74.3%  
Inventory Days Days26333 806.4%  
Debtors Days Days34367 511.9%  
Net fixed assets Rs m10,61737,245 28.5%   
Share capital Rs m166239 69.4%   
"Free" reserves Rs m7,26590,208 8.1%   
Net worth Rs m7,43190,447 8.2%   
Long term debt Rs m00-   
Total assets Rs m22,330124,541 17.9%  
Interest coverage x409.113.2 3,109.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 59.1%   
Return on assets %10.38.9 115.3%  
Return on equity %30.911.1 277.4%  
Return on capital %42.415.6 271.5%  
Exports to sales %014.6 0.0%   
Imports to sales %13.10-   
Exports (fob) Rs mNA16,916 0.0%   
Imports (cif) Rs m1,605NA-   
Fx inflow Rs m1,46516,916 8.7%   
Fx outflow Rs m1,6054,190 38.3%   
Net fx Rs m-14012,727 -1.1%   
CASH FLOW
From Operations Rs m2,36016,825 14.0%  
From Investments Rs m-2151,128 -19.1%  
From Financial Activity Rs m-985-17,608 5.6%  
Net Cashflow Rs m1,160416 278.8%  

Share Holding

Indian Promoters % 0.0 56.7 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 24.4 83.0%  
FIIs % 7.6 8.5 89.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 43.3 111.4%  
Shareholders   56,730 65,184 87.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs ALKEM LABORATORIES Share Price Performance

Period Procter & Gamble Health ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -0.55% -1.18% 1.18%
1-Month -7.47% -0.99% -0.75%
1-Year -3.02% 52.26% 61.82%
3-Year CAGR -9.12% 21.70% 18.16%
5-Year CAGR 5.75% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.